Abstract

Musculoskeletal diseases, encompassing a wide range of conditions affecting bones, cartilage, muscles, and connective tissues, present significant challenges in healthcare, often resulting in pain, loss of function, and reduced quality of life for patients. Regenerative medicine, particularly tissue engineering, has emerged as a promising approach for treating musculoskeletal disorders by utilizing biomaterials to promote tissue repair and regeneration. Among these biomaterials, silk fibroin has garnered considerable attention due to its unique properties and versatile applications. This abstract provides an overview of the potential of silk fibroin-based biomaterials in the treatment of musculoskeletal diseases.